San Leandro, CA (PRWEB) March 29, 2013
Turner Eye Institute, a full-service eye care center, recently announced that it is the first in the local community to introduce a new treatment for patients who suffer from Evaporative Dry Eye. This disease stems from a deficiency in the oily lipid layer of the eye’s natural tear film. The oily lipids serve as a protective layer so that the aqueous (water) layer of the eye’s tear film does not evaporate.
Turner Eye Institute has introduced a new, advanced in-office treatment, called LipiFlow®, which is intended to treat patients with blocked meibomian glands, called meibomian gland dysfunction, by unblocking the glands and allowing them to resume the secretion of oily lipids needed for a healthy tear film.
Dry eye disease affects more than 100 million people worldwide. Of those, 65 percent suffer from Evaporative Dry Eye. Common symptoms of dry eye include dryness, grittiness, soreness, irritation, burning and eye fatigue. These symptoms can hinder people’s daily activities such as reading, using the computer, wearing contact lenses and being outdoors on windy days. Many dry eye patients complain those symptoms worsen throughout the day.
“Dry eye disease is one of the most common topics patients discuss when visiting eye care professionals,” said Chirag R. Patel, MD at Turner Eye Institute. “We are very pleased to introduce the new LipiFlow® treatment to help those patients who are very frustrated with this chronic disease and all of the ways it negatively impacts their lives. In effect, LipiFlow® helps the meibomian glands resume their natural function and many patients note symptom relief.”
Historically, common therapies aimed at dry eye symptom relief included using warm compresses, over- the-counter wetting drops and ointments, and prescription drugs. Alternatively, the new LipiFlow® treatment addresses the root cause of evaporative dry eye by unblocking the meibomian glands that secrete oily lipids. In controlled clinical studies of patients who received a single LipiFlow® treatment, the average meibomian gland score at four weeks increased by two to three times over the baseline condition, which reflects improvement in the number of glands secreting and secretion quality. Additionally, at four weeks after the LipiFlow® treatment, 79 percent of patients reported improvement in dry eye symptoms.
Dr. Stephen Turner has been providing corrective eye surgery (and most recently LASIK surgery) to residents of San Francisco, Oakland, San Jose, Concord, and the Greater San Francisco Bay Area since 1976. He is a Board Certified Ophthalmologist and a trained fellow at the American College of Surgeons. In addition to being a full-time LASIK surgeon and refractive surgery specialist, Dr. Turner provides lectures about LASIK surgery throughout the Greater San Francisco Bay Area.
Dr. Patel specializes in the diagnosis and treatment of diseases of the cornea, anterior segment, and lens. He particularly enjoys cataract/intraocular lens surgery, refractive procedures, keratoconus treatments and corneal transplantation including cutting edge techniques such as partial thickness transplants.
The quality of eye care ultimately depends on the skills of the surgeon. Dr. Turner and Dr. Patel are specially trained in treating eye diseases and performing eye surgery.
About the company:
Turner Eye Institute provides an array of eye care services for those who need to get eye surgery, including laser vision correction, refractive and cataract surgery and evaporative dry eye treatment. Their world renowned surgeons have outstanding credentials to deliver the best care and surgical outcomes for patients. Turner Eye Institute utilizes the most advanced, field proven technology to deliver the best solutions safely and reliably. Recent advances in LASIK eye surgery technology can be found at all of Turner Eye Institute's clinics in San Francisco, Concord, San Jose, and San Leandro and the Entire Bay Area.